IP Library Granted Patent US 11,421,206
Granted Patent B2
US 11,421,206 · App. 16/661,667 · Granted Aug 23, 2022

Omega-hydroxylase-related fusion polypeptides with improved properties

Inventors: Baolong Zhu (San Diego, CA); Andreas W. Schirmer (San Diego, CA); Cindy Chang (San Diego, CA)
Assignee: Genomatica, Inc.
C12N9/0077C12P7/6409
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,421,206
App. No.
16/661,667
Granted
Aug 23, 2022
Kind
B2
Abstract

The disclosure relates to omega-hydroxylase-related fusion polypeptides that result in improved omega-hydroxylated fatty acid derivative production when expressed in recombinant host cells. The disclosure further relates to microorganisms for expressing the omega-hydroxylase-related fusion polypeptides for the production of omega-hydroxylated fatty acid derivatives.

Claims (10)

1. A CYP153A-reductase hybrid fusion polypeptide variant comprising at least 95% sequence identity to SEQ ID NO: 38 and having at least one mutation at an amino acid position corresponding to amino acid position 56, 61, 111, 140, 162, 164, 204, 244, 254, 273, 302, 477, 480, 481, 527, 544, 546, 557, 567, 591, 648, 649, 706, 707, 708, 709, 710, 719, 720, 736, and 741 of SEQ ID NO: 38, wherein the CYP153A reductase hybrid fusion polypeptide variant catalyzes conversion of a fatty acid to an omega-hydroxylated fatty acid.

2. The CYP153A-reductase hybrid fusion polypeptide variant of claim 1 , wherein the mutation is selected from the group consisting of P56Q, N61L, F111A, 5140N, V162C, A164N, G204V, A244R, R254G, P273M, T302M, P477G, I480G, G481I, D527E, D544N, P546G, E557W, E557R, E567S, E591Q, V648L, S649I, L706H, L706E, L706S, D707E, P708S, D709L, V710C, V710R, V710Q, R719W, D720V, A736V, and N741G.

3. A recombinant host cell comprising the CYP153A-reductase hybrid fusion polypeptide variant of claim 1 .

4. A cell culture comprising the recombinant host cell of claim 3 .

5. A method for producing an omega-hydroxylated fatty acid, the method comprising: culturing the recombinant host cell of claim 3 in a fermentation broth comprising a carbon source.

6. The method of claim 5 , further comprising isolating the omega-hydroxylated fatty acid.

7. The method of claim 5 , wherein the recombinant host cell further comprises an exogenous thioesterase polypeptide of EC 3.1.2.14 or EC 3.1.1.5.

8. The method of claim 7 , wherein the recombinant host cell produces a omega-hydroxylated fatty acid with a titer that is at least 10% greater, at least 15% greater, at least 20% greater, at least 25% greater, or at least 30% greater than the titer of an omega-hydroxylated fatty acid produced by a recombinant host cell comprising a corresponding CYP153A-reductase hybrid fusion polypeptide of SEQ ID NO: 38.

9. The method of claim 5 , wherein the omega-hydroxylated fatty acid comprises one or more of a C 12 , C 16 and a C 16:1 omega-hydroxylated fatty acid.

10. The method of claim 5 , wherein the omega-hydroxylated fatty acid is produced intracellularly or extracellularly.

Assignments (5)
SECURITY INTEREST Recorded Feb 10, 2026
From: GENOMATICA, INC.
To: AGAIN BIO APS
Reel/Frame 074708/0001 →
SECURITY INTEREST Recorded Dec 9, 2025
From: GENOMATICA, INC.
To: NOVO HOLDINGS A/S, AS COLLATERAL AGENT
Reel/Frame 073915/0027 →
SECURITY INTEREST Recorded Jun 2, 2025
From: GENOMATICA, INC.
To: OXFORD FINANCE LLC
Reel/Frame 071471/0770 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 25, 2022
From: REG LIFE SCIENCES, LLC
To: GENOMATICA, INC.
Reel/Frame 059504/0013 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 25, 2022
From: ZHU, BAOLONG; SCHIRMER, ANDREAS W.; CHANG, CINDY
To: REG LIFE SCIENCES, LLC
Reel/Frame 059403/0252 →
Cited By (1)
US 12,595,495